JP2003528139A5 - - Google Patents

Download PDF

Info

Publication number
JP2003528139A5
JP2003528139A5 JP2001570257A JP2001570257A JP2003528139A5 JP 2003528139 A5 JP2003528139 A5 JP 2003528139A5 JP 2001570257 A JP2001570257 A JP 2001570257A JP 2001570257 A JP2001570257 A JP 2001570257A JP 2003528139 A5 JP2003528139 A5 JP 2003528139A5
Authority
JP
Japan
Prior art keywords
xanthophyll
expression
astaxanthin
animal
agent according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001570257A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003528139A (ja
Filing date
Publication date
Priority claimed from SE0001071A external-priority patent/SE0001071D0/xx
Application filed filed Critical
Publication of JP2003528139A publication Critical patent/JP2003528139A/ja
Publication of JP2003528139A5 publication Critical patent/JP2003528139A5/ja
Pending legal-status Critical Current

Links

JP2001570257A 2000-03-27 2001-03-21 炎症性サイトカインおよびケモカインの発現を阻害する方法 Pending JP2003528139A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0001071-0 2000-03-27
SE0001071A SE0001071D0 (sv) 2000-03-27 2000-03-27 Method of inhibiting the expression of inflammatory cytokines and chemokines
PCT/SE2001/000600 WO2001072296A1 (en) 2000-03-27 2001-03-21 Method of inhibiting the expression of inflammatory cytokines and chemokines

Publications (2)

Publication Number Publication Date
JP2003528139A JP2003528139A (ja) 2003-09-24
JP2003528139A5 true JP2003528139A5 (cg-RX-API-DMAC7.html) 2008-05-15

Family

ID=20279020

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001570257A Pending JP2003528139A (ja) 2000-03-27 2001-03-21 炎症性サイトカインおよびケモカインの発現を阻害する方法

Country Status (8)

Country Link
EP (1) EP1267857B1 (cg-RX-API-DMAC7.html)
JP (1) JP2003528139A (cg-RX-API-DMAC7.html)
AT (1) ATE353639T1 (cg-RX-API-DMAC7.html)
AU (1) AU2001242965A1 (cg-RX-API-DMAC7.html)
CA (1) CA2405479C (cg-RX-API-DMAC7.html)
DE (1) DE60126591D1 (cg-RX-API-DMAC7.html)
SE (1) SE0001071D0 (cg-RX-API-DMAC7.html)
WO (1) WO2001072296A1 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003048202A2 (en) * 2001-12-03 2003-06-12 Asahi Kasei Pharma Corporation Nf-kappab activating genes
EP2653157B1 (en) * 2004-02-04 2016-08-03 Fuji Chemical Industry Co., Ltd. Astaxanthin for improving muscle atrophy
JP2006008714A (ja) * 2005-03-17 2006-01-12 Yamaha Motor Co Ltd マトリックスメタロプロテイナーゼ阻害剤
JP2006008718A (ja) * 2005-06-03 2006-01-12 Yamaha Motor Co Ltd シクロオキシゲナーゼ活性阻害剤
JP2006008719A (ja) * 2005-06-23 2006-01-12 Yamaha Motor Co Ltd 血中過酸化脂質抑制剤
US7805004B2 (en) * 2007-02-28 2010-09-28 Microsoft Corporation Radical set determination for HMM based east asian character recognition
WO2008106606A2 (en) * 2007-02-28 2008-09-04 Cardax Pharmaceuticals, Inc. Carotenoid analogs and derivatives in the treatment of prostate cancer

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05155736A (ja) * 1991-12-10 1993-06-22 Nakano Seiyaku Kk 化粧料
JPH0799924A (ja) * 1993-09-30 1995-04-18 Nippon Suisan Kaisha Ltd アスタキサンチンを主要成分とするファフィア色素油の安定な粉末化物及びその製造方法
JPH07300421A (ja) * 1994-04-28 1995-11-14 Itano Reitou Kk 抗炎症剤
US5527533A (en) * 1994-10-27 1996-06-18 Board Of Trustees Of The University Of Illinois Method of retarding and ameliorating central nervous system and eye damage
US5886053A (en) * 1995-02-03 1999-03-23 Basf Aktiengesellschaft Use of carotenoids for producing drugs for the treatment of dermatoses
JPH09124470A (ja) * 1995-10-26 1997-05-13 Suntory Ltd 抗ストレス組成物
JPH09143063A (ja) * 1995-11-22 1997-06-03 Kose Corp 外用に適する組成物
SE522246C2 (sv) * 1997-02-27 2004-01-27 Astacarotene Ab Oralt preparat för profylaktisk och terapeutisk behandling av Helicobacter Sp. infektion
EP0984915A4 (en) * 1997-04-04 2002-11-27 Henkel Corp LUTEINE ESTERS WITH HIGH BIOAVAILABILITY
SE512531C2 (sv) * 1997-09-04 2000-03-27 Astacarotene Ab Användning av åtminstone en typ av xantofyller för framställning av ett läkemedel för profylaktisk och/eller terapeutisk förbättring av muskelfunktionsdurationen hos däggdjur och/eller behandling av muskelstörningar eller - sjukdomar hos däggdjur

Similar Documents

Publication Publication Date Title
DE60134855D1 (de) Orale zubereitungen, die antimikrobielle wirkstoffe enthalten zur prävention von systemischen erkrankungen
ITMI20020399A1 (it) Composizioni dietetiche e/o farmaceutiche per uso umano e/o animale abase di preparati microbici probiotici
NO20056223L (no) Preparat til behandling av infeksjon hos kveg og svin
CY1118519T1 (el) Συνθεση τετρακυκλινων και αναλογων αυτων
ATE241352T1 (de) Omega-3-fettsäurehaltige zubereitung aus mikroorganismen als prophylaktikum bzw. therapeutikum gegen kokzidiose bei tieren
PE20040751A1 (es) COMPOSICION FARMACEUTICA QUE COMPRENDE DOSIS BAJAS DE UN INHIBIDOR DEL TNFalfa HUMANO
DE60331583D1 (de) Phosphoantigen enthaltene zusammensetzungen zur regulierung von immunereaktionen
CY1110061T1 (el) Συνθεσεις περιλαμβανοντας ενωσεις μοδαφινιλης
AR098251A2 (es) Uso de aivlosin o de una sal de adición ácida del mismo farmacológicamente aceptada para la preparación de un medicamento de uso veterinario, un alimento para aves de corral o cerdos, una composición recubierta estable para ser agregada a dicho alimento y un medicamento de uso veterinario
PT1401415E (pt) Utilizacao de derivados de n-fenil-2-pirimidino-amina para o tratamento de doencas inflamatorias
DK1401413T3 (da) Anvendelse af tyrosinkinaseinhibitorer til behandling af allergiske sygdomme
WO2003004007A3 (en) Use of tyrosine kinase inhibitors for treating inflammatory bowel diseases (ibd)
CO5221025A1 (es) 4-trifluorometil-3-oxazolilpiridinas, procedimiento para su preparacion, agentes que las contienen y su uso como agente para la lucha contra organismos daninos
WO2003002105A3 (en) Use of tyrosine kinase inhibitors for treating bone loss
ATE297223T1 (de) Teilchenförmige vitaminzubereitung
NO975191L (no) Diaromatiske propynyl- eller dienylforbindelser
ATE401078T1 (de) Die verwendung von c-kithemmern zur förderung des haarwuchses
WO2002064558A3 (en) Oxazole derivatives, their preparation and their use as cytokine inhibitors
AR042677A1 (es) Composiciones y metodos de cuidado oral
SE9704590D0 (sv) Method of increasing the production and improving the quality of semen
CR7515A (es) Composicion veterinaria inyectable para animales pequenos
SE0001071D0 (sv) Method of inhibiting the expression of inflammatory cytokines and chemokines
WO2001080891A8 (en) Remedies for interstitial pneumonia, method of constructing animal model of this disease and screening method with the use of the same
AR000555A1 (es) Uso de composiciones anabolicas para la masa osea en base a cantidades efectivas no toxicas del ácido Ä3-(n,n-dimetilamino)-1-hidroxipropilidenoÜbisfosfonico o la sal monosodica u otra sal farmacéuticamente aceptable del mismo
BRPI0417692A (pt) uso de uma composição, método de redução dos efeitos do estresse mediado psicologicamente na pele de um ser humano ou animal, composição, suplemento nutritivo, composição cosmética, e, método para identificar um composto capaz de reduzir os efeitos e método de produção de uma composição para a redução dos efeitos, do estresse mediado psicologicamente sobre a pele de um ser humano ou animal